ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

AMYT Amryt Pharma Plc

143.00
0.00 (0.00%)
01 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Amryt Pharma Plc LSE:AMYT London Ordinary Share GB00BKLTQ412 ORD 6P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 143.00 151.00 170.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Amryt Pharma Share Discussion Threads

Showing 4826 to 4843 of 7375 messages
Chat Pages: Latest  199  198  197  196  195  194  193  192  191  190  189  188  Older
DateSubjectAuthorDiscuss
05/8/2019
16:46
I've forgotten. What's the potential timetable re the merger?
waterloo01
05/8/2019
13:53
Any day now
alphabravo321
31/7/2019
16:17
You are, chica1, like the rest of us an anonymous poster so I have no idea whether you are telling the truth, or not.

I must admit to finding it strange that one who does "not own any stocks" should be posting on a bb of a site, ADVFN, that caters solely for private investors. I'm surprised you even bothered to look for the site.

Of course you are entitled to your opinion and if you are telling the truth and have found, in your experience, that Episalvan is not that effective (if at all) you might be the exception that proves the rule. After all that's no doubt why AMYT had to increase the size of the phase III trial and increase the patient numbers. I doubt if there is any drug, or treatment, currently on sale that is effective for every patient. We'll have to await the final phase III results to find out whether your experiences (if you are being truthful) with Episalvan are the exception, or the norm!

papillon
31/7/2019
16:05
mdalos1
31 Jul '19 - 00:19 - 4692 of 4693
0 0 0
POT KETTLE.... 100s of posts on here almost all of the time, relentlessly at times, including copy/pasting other people's posts AND having "arguments" here with Posters on an entirely different BB !!!!

How ironic... LOLs

Do you think you'll be down 65% or maybe as much as 75% when the dust settles ?

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

ROFLMAO. PMSL. I thought I'd copy your words of wisdom (LOL) for posterity before you delete them! I make no prediction of the likely share price when they relist, MADLOSS, unlike you! You have nailed your colours to the mast. When they relist I can refer to this post to see if you were right, or wrong!

PS. Every time I post on this bb, you follow suit, MADLOSS. Are you stalking me? If you want to get to know me better just post me a message and we can arrange to meet up somewhere. We can then have a little chat! Close up and personal! LOL

papillon
31/7/2019
00:29
I do not own any stocks.
I am probably here for selfish reasons in the hope of relief for the condition that afflicts my family.

chica1
30/7/2019
21:31
PMSL. ROFLMAO. Okay, chica1. We've got the message! So you're doing your own single patient AP101 phase III trial. It's a shame that AMYT are conducting a phase III AP101 trial with circa 200 patients in different locations. How very wasteful of AMYT. They could have done a single patient phase III trial like yours and saved a fortune! PMSL ROFLMAO.

16 posts since you joined ADVFN in February of this year. All negative and all on AMYT. Don't you have any interest in other shares? How very strange!

papillon
30/7/2019
18:56
Got our hands on some Episalvan again.
Skin conditions tend to flair up in hot an clammy weather.
We're not seeing ground breaking results.

chica1
24/7/2019
11:18
RNS targets early Q4 for re admission to AIM
alphabravo321
22/7/2019
09:04
thank you. Do we have any guestimate day for re-listing on AIM?
medicman1
20/7/2019
23:49
mdalos1
20 Jul '19 - 13:23 - 4684 of 4685
0 0 0
LOLs !!

Nearly there now then... next step is realising approx. a 65% loss, unless a relatively brief opportunity to sell in the UK AIM Market avails itself before all instruments have been exercised and all Business deals are closed, with the consequences eventually hitting home hard.

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

So Nostradamus is predicting I will suffer a 65% loss on my AMYT shares. He obviously needs a new crystal ball as his present one is leading him astray.

I'm hopeful that by listing on Nasdaq AMYT will receive the recognition it has sadly lacked on AIM. Biotechs are invariably much higher rated on Nasdaq than AIM.

papillon
20/7/2019
13:43
Whoops Madloss.... forgot to take your olanzapine & resperidone tablets this morning? When you remember... you will likely start erasing your postings again! LOL!
diamondstar1
20/7/2019
11:12
Thanks for clarifying that, Strangeman. I was mystified, but then I have an excuse; I'm old. Apart from reading and posting on some ADVFN message boards I never use social media.

Regarding LOL, I remember years ago David Cameron thought it meant "Lots of Love" when corresponding to his then horse riding pal, Rebekah Brooks.

papillon
19/7/2019
16:21
"4 chars"?????????????????????????????
papillon
19/7/2019
13:22
same as the last 4 chars of your post. Another waste of bandwidth
strangeman
19/7/2019
10:07
Yes, many thanks, alphabravo321, for posting that link. I also concur with delta0091. AMYT do appear to have got a bargain. Let's hope investors agree when AMYT relists on AIM and lists on NASDAQ.

I was too late to read mdalos's words of wisdom as he'd already deleted his post by the time I looked at this bb. Did I miss much? LOL.

papillon
18/7/2019
21:28
thanks alphabravo
bermudashorts
18/7/2019
15:48
I have the exact same view!
alphabravo321
18/7/2019
14:46
if a fund manager had objection to the deal then it speaks volumes - they felt AMYT had got the acquisition on the cheap. AMYT seems to have pulled off a blinder here taking advantage of historical baggage affecting the company, yet buying a perfectly sound company.
delta0091
Chat Pages: Latest  199  198  197  196  195  194  193  192  191  190  189  188  Older

Your Recent History

Delayed Upgrade Clock